NAD+ comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-12-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Quality control for NMN materials typically includes identity, assay, purity, and impurity profiling. Tests may cover residual solvents, heavy metals, microbial limits, and water content, depending on the intended use and local rules. Impurity profiles can include related substances such as nicotinamide, nicotinamide riboside, and NAD+, which may form during synthesis or storage. Because commercial NMN can be offered as different salts or hydrate forms, a certificate of analysis should state the form and the analytical methods used. Independent verification is relevant because supplement markets vary in testing requirements and enforcement.
Laboratory identification of NMN usually relies on chromatographic separation coupled with ultraviolet or mass spectrometric detection. High-performance liquid chromatography with UV absorbance can quantify the compound against a reference standard, while liquid chromatography-tandem mass spectrometry offers lower detection limits and better specificity in complex matrices. Nuclear magnetic resonance spectroscopy can confirm structural identity and isomeric form. Ion chromatography or capillary electrophoresis may be used to identify counterions such as sodium. Method validation includes accuracy, precision, linearity, and limits of detection.
NMN occurs in many living systems, including bacteria, yeast, plants, and mammals. Dietary sources are present in foods such as edamame, avocado, broccoli, and various meats, but amounts vary widely and are generally lower than those used in research settings. Laboratory production often relies on enzymatic synthesis or chemical phosphorylation of nicotinamide riboside, and commercial material is typically supplied as a white to off-white powder. Because NMN is hygroscopic and sensitive to heat, moisture, and pH extremes, its handling requires care to preserve identity and purity. Aqueous preparation should be done with attention to pH and temperature to limit hydrolysis.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure consists of a nicotinamide ring linked to ribose phosphate, and the compound serves as an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+. In this pathway, nicotinamide phosphoribosyltransferase converts nicotinamide and phosphoribosyl pyrophosphate into NMN, after which NMN adenylyltransferase attaches an adenylate group to produce NAD+. Because NAD+ participates in redox reactions and signaling, NMN occupies a central position in cellular metabolism. The molecule is distinct from nicotinamide riboside, though the two are related in NAD+ precursor research.
| Property | Value | Notes |
|---|---|---|
| Typical assay method | HPLC with UV detection | Often at 254 or 260 nm; LC-MS/MS used for trace analysis. |
| Storage temperature | -20 °C or below | Dry powder; protect from light and moisture. |
| Aqueous stability | Limited | Solutions may hydrolyze or dephosphorylate; prepare fresh when possible. |
| Counterion check | Ion chromatography | Identifies sodium or other counterions in salt forms. |
| Common related impurities | Nicotinamide, nicotinamide riboside, NAD+ | Monitored by chromatographic purity methods. |
Quality control for NMN focuses on identity, purity, residual solvents, heavy metals, and microbial limits. Because the molecule can absorb water, moisture content and packaging are relevant to shelf life. Suppliers may provide certificates of analysis, but independent verification is often needed for research or commercial use. The long-term stability of different crystal forms, salt forms, and formulations is not fully characterized in the public literature. Some degradation products and their effects on product performance remain open questions.
As a commercial ingredient, nicotinamide mononucleotide is commonly supplied as a powder or capsule. Its stability depends on temperature, moisture, pH, and light exposure. Hydrolytic and thermal degradation can increase over time, so manufacturers and laboratories often store material cold and dry. Purity is typically assessed with chromatographic methods, and identity can be confirmed by mass spectrometry. Published stability data for specific finished products remain limited. More data would help define shelf life under real-world conditions.
Regulatory treatment varies by country. In the United States, NMN has been marketed as a dietary supplement, but the Food and Drug Administration has stated that it is excluded from the dietary supplement definition because it was authorized for investigation as a new drug before being marketed as a supplement. Other jurisdictions may treat it as a novel food, a supplement, or an unapproved drug ingredient. Import and sale rules can therefore differ substantially.
Two enzymatic steps define the canonical route from nicotinamide to NAD+. Nicotinamide phosphoribosyltransferase, known as NAMPT, produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN adenylyltransferases, or NMNAT enzymes, then couple NMN with ATP to form NAD+. Whether intact NMN crosses cell membranes efficiently remains an active area of investigation; some studies propose direct transport, while others emphasize extracellular dephosphorylation to nicotinamide riboside followed by uptake. The relative contribution of each route likely depends on cell type, tissue, and experimental conditions.
Trace amounts of NMN have been reported in certain plant foods, including edamame, avocado, broccoli, cucumber, and cabbage. Reported concentrations vary widely because analytical methods differ and food matrices complicate extraction. Endogenous production in cells is generally considered more quantitatively important than dietary intake, though precise human turnover rates are difficult to establish. Commercial NMN for research or consumer products is commonly made through enzymatic synthesis or chemical phosphorylation routes. Regulatory classification differs by country; in some jurisdictions NMN is sold as a supplement, while in others it is treated as a novel food ingredient or restricted substance.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. As an intermediate in the NAD+ salvage pathway, NMN is converted to nicotinamide adenine dinucleotide, a coenzyme central to cellular redox reactions. NAD+ also serves as a substrate for enzymes involved in DNA repair, stress responses, and metabolic regulation. The compound is therefore part of normal cellular biochemistry rather than an exclusively synthetic molecule.
Quality control for NMN typically checks identity, assay purity, residual solvents, heavy metals, and microbial limits, depending on the intended use and market. A certificate of analysis may report appearance, solubility, water content, and storage recommendations. Independent verification can compare chromatographic retention time and mass spectrum against a certified reference standard. Regulatory expectations differ between research chemicals, dietary ingredients, and pharmaceutical products. Impurity profiles and stability data are often requested for product approval, and open questions remain about how best to standardize NMN measurements across laboratories.
NMN is a polar, water-soluble nucleotide. In solid form it is usually a white to off-white powder. The compound is sensitive to heat, light, moisture, and extremes of pH, and aqueous solutions tend to degrade faster than dry material. Recommended storage for research samples is typically -20 °C or below in a sealed, desiccated container protected from light. Repeated freeze-thaw cycles should be avoided, and these handling practices help maintain identity and purity during laboratory use.
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide ring attached to a ribose sugar that carries a phosphate group. The molecular formula is C11H15N2O8P, and the molar mass is about 334.22 grams per mole. In cells, NMN is an intermediate in the salvage pathway that recycles nicotinamide to maintain NAD+ levels. It is not the same compound as NAD+, although it is a direct precursor in one enzymatic step.
=== EC 1.13.11 With incorporation of two atoms of oxygen === EC 1.13.11.1: catechol 1,2-dioxygenase EC 1.13.11.2: catechol 2,3-dioxygenase EC 1.13.11.3: protocatechuate 3,4-dioxygenase EC 1.13.11.4: gentisate 1,2-dioxygenase EC 1.13.11.5: homogentisate 1,2-dioxygenase EC 1.13.11.6: 3-hydroxyanthranilate 3,4-dioxygenase EC 1.13.11.7: deleted EC 1.13.11.8: protocatechuate 4,5-dioxygenase EC 1.13.11.9: 2,5-dihydroxypyridine 5,6-dioxygenase EC 1.13.11.10: 7,8-dihydroxykynurenate 8,8a-dioxygenase EC 1.13.11.11: tryptophan 2,3-dioxygenase EC 1.13.11.12: linoleate 13S-lipoxygenas EC 1.13.11.13: The activity is the sum of several enzymatic and spontaneous reactions EC 1.13.11.14: 2,3-dihydroxybenzoate 3,4-dioxygenase EC 1.13.11.15: 3,4-dihydroxyphenylacetate 2,3-dioxygenase EC 1.13.11.16: 3-carboxyethylcatechol 2,3-dioxygenase EC 1.13.11.17: indole 2,3-dioxygenase EC 1.13.11.18: persulfide dioxygenase EC 1.13.11.19: cysteamine dioxygenase EC 1.13.11.20: cysteine dioxygenase EC 1.13.11.21: Now EC 1.14.99.36, β-carotene 15,15′-monooxygenase EC 1.13.11.22: caffeate 3,4-dioxygenase EC 1.13.11.23: 2,3-dihydroxyindole 2,3-dioxygenase EC 1.13.11.24: quercetin 2,3-dioxygenase EC 1.13.11.25: 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5-dioxygenase EC 1.13.11.26: peptide-tryptophan 2,3-dioxygenase EC 1.13.11.27: 4-hydroxyphenylpyruvate dioxygenase EC 1.13.11.28: 2,3-dihydroxybenzoate 2,3-dioxygenase EC 1.13.11.29: stizolobate synthase EC 1.13.11.30: stizolobinate synthase EC 1.13.11.31: arachidonate 12-lipoxygenase EC 1.13.11.32: Now EC 1.13.12.16, nitronate monooxygenase EC 1.13.11.33: arachidonate 15-lipoxygenase EC 1.13.11.34: arachidonate 5-lipoxygenase EC 1.13.11.35: pyrogallol 1,2-oxygenase EC 1.13.11.36: chloridazon-catechol dioxygenase EC 1.13.11.37: hydroxyquinol 1,2-dioxygenase EC 1.13.11.38: 1-hydroxy-2-naphthoate 1,2-dioxygenase EC 1.13.11.39: biphenyl-2,3-diol 1,2-dioxygenase EC 1.13.11.40: arachidonate 8-lipoxygenase EC 1.13.11.41: 2,4′-dihydroxyacetophenone dioxygenase EC 1.13.11.42: identical to EC 1.13.11.11, tryptophan 2,3-dioxygenase EC 1.13.11.43: lignostilbene αβ-dioxygenase EC 1.13.11.44: Activity is covered by EC 1.13.11.60, linoleate 8R-lipoxygenase and EC 5.4.4.6, 9,12-octadecadienoate 8-hydroperoxide 8S-isomerase EC 1.13.11.45: linoleate 11-lipoxygenase EC 1.13.11.46: 4-hydroxymandelate synthase EC 1.13.11.47: 3-hydroxy-4-oxoquinoline 2,4-dioxygenase EC 1.13.11.48: 3-hydroxy-2-methyl-quinolin-4-one 2,4-dioxygenase EC 1.13.11.49: chlorite O2-lyase EC 1.13.11.50: acetylacetone-cleaving enzyme EC 1.13.11.51: 9-cis-epoxycarotenoid dioxygenase EC 1.13.11.52: indoleamine 2,3-dioxygenase EC 1.13.11.53: acireductone dioxygenase (Ni2+-requiring) EC 1.13.11.54: acireductone dioxygenase [iron(II)-requiring] EC 1.13.11.55: sulfur oxygenase/reductase EC 1.13.11.56: 1,2-dihydroxynaphthalene dioxygenase EC 1.13.11.57: gallate dioxygenase EC 1.13.11.58: linoleate 9S-lipoxygenase EC 1.13.11.59: torulene dioxygenase EC 1.13.11.60: inoleate 8R-lipoxygenase EC 1.13.11.61: linolenate 9R-lipoxygenase EC 1.13.11.62: linoleate 10R-lipoxygenase EC 1.13.11.63: β-carotene 15,15′-dioxygenase EC 1.13.11.64: 5-nitrosalicylate dioxygenase EC 1.13.11.65: carotenoid isomerooxygenase EC 1.13.11.66: hydroquinone 1,2-dioxygenase EC 1.13.11.67: 8′-apo-β-carotenoid 14′,13′-cleaving dioxygenase EC 1.13.11.68: 9-cis-β-carotene 9′,10′-cleaving dioxygenase EC 1.13.11.69: carlactone synthase EC 1.13.11.70: all-trans-10′-apo-β-carotenal 13,14-cleaving dioxygenase EC 1.13.11.71: carotenoid-9′,10′-cleaving dioxygenase EC 1.13.11.72: 2-hydroxyethylphosphonate dioxygenase EC 1.13.11.73: methylphosphonate synthase EC 1.13.11.74: 2-aminophenol 1,6-dioxygenase EC 1.13.11.75: all-trans-8′-apo-β-carotenal 15,15′-oxygenase EC 1.13.11.76: 2-amino-5-chlorophenol 1,6-dioxygenase EC 1.13.11.77: oleate 10S-lipoxygenase EC 1.13.11.78: 2-amino-1-hydroxyethylphosphonate dioxygenase (glycine-forming) EC 1.13.11.79: aerobic 5,6-dimethylbenzimidazole synthase EC 1.13.11.80: (3,5-dihydroxyphenyl)acetyl-CoA 1,2-dioxygenase EC 1.13.11.81: 7,8-dihydroneopterin oxygenase EC 1.13.11.82: 8′-apo-carotenoid 13,14-cleaving dioxygenase EC 1.13.11.83: 4-hydroxy-3-prenylphenylpyruvate oxygenase EC 1.13.11.84: crocetin dialdehyde synthase EC 1.13.11.85: exo-cleaving rubber dioxygenase EC 1.13.11.86: 5-aminosalicylate 1,2-dioxygenase EC 1.13.11.87: endo-cleaving rubber dioxygenase EC 1.13.11.88: isoeugenol monooxygenase EC 1.13.11.89: (hydroxymethyl)phosphonate dioxygenase EC 1.13.11.90: [1-hydroxy-2-(trimethylamino)ethyl]phosphonate dioxygenase (glycine-betaine-forming) EC 1.13.11.91: 3-mercaptopropionate dioxygenase EC 1.13.11.92: fatty acid α-dioxygenase
== Thermodynamics == Self-assembly is an equilibrium process, i.e. the individual and assembled components exist in equilibrium. In addition, the flexibility and the lower free energy conformation is usually a result of a weaker intermolecular force between self-assembled moieties and is essentially enthalpic in nature. The thermodynamics of the self-assembly process can be represented by a simple Gibbs free energy equation:
=== Differential diagnosis === Other conditions that can cause bluish skin include argyria, sulfhemoglobinemia, heart failure, amiodarone-induced bluish skin pigmentation and acrodermatitis enteropathica.
=== Deleterious === Deleterious outcomes represent the majority of nonsense mutations and are the most common outcome that is observed naturally. Deleterious nonsense mutations decrease the overall fitness and reproductive success of the organism. For example, a nonsense mutation occurring in a gene encoding a protein can cause structural or functional defects in the protein that disrupt cellular biology. Depending on the significance of the functions of this protein, this disruption could be detrimental to the fitness and survival of that organism.
"Biosafety in Microbiological and Biomedical Laboratories", official CDC guide. "Prevention of Biological Hazards", EU-OSHA "Symbol Making", an account of the development of the symbol in 1966. "BioSeal Systems", Biosafety level 4 containment. Biohazard Remediation Compliance Overview "Example of Reclassified Biohazard to Level 4", article from The Lancet concerning the reclassification of Ebola after observation. "Biological hazards related to working alone safety", an article focusing on working alone safety when dealing with biological hazards
Sources: en.wikipedia.org
Also in 2018, she had a recurring role in the CBS comedy series Murphy Brown playing the role of a network boss. In 2020, Dandridge was cast in a series regular role in the eight-episode HBO Max thriller drama series The Flight Attendant. In 2021, she was cast to reprise her role as Marlene from the critically acclaimed game The Last of Us, in the HBO series of the same name. On January 9, 2025, it was announced that Dandridge would be taking over the role of Persephone in the Broadway production of Hadestown starting February 18. In March 2026, it was announced that Dandridge joined the main cast of USA Network's legal drama series, The Rainmaker, in its second season.
== Early years and education == Hans Charles Freeman was the first and only son of Karl and Lotte Freeman and was born in Breslau in Germany in 1929 (now Wrocław, Poland). In 1938, following a tip-off from a Nazi party member, Karl decided to relocate his Jewish family to Australia. Karl brought his knowledge of detergents (a novelty in Australia at the time) to his new homeland, applying it to the problem of cleaning blood-stained blankets that would otherwise be wasted. After the war, he founded K. H. Freeman Pty Ltd, a detergent and soap manufacturing company; Hans spent many weekends working in the factory, gaining a practical insight into chemistry. Hans adapted well to his new environment, quickly mastering his new language and demonstrating his outstanding scholastic ability. He was dux of his primary school, dux of Sydney Boys High in 1945, and took his bachelor's degree with the university medal in chemistry in 1949. He was one of the ten chemistry students in his class at Sydney Boys High to go on to become Professors of Chemistry. After receiving his MSc in 1952 under the supervision of Raymond Le Fèvre FRS, Freeman attended Caltech on a Rotary Foundation Fellowship where, at the urging of Linus Pauling, he learned the fundamentals of crystallography. He received a PhD in 1957 for his work on the structure of biuret hydrate, where he completed most of the calculations for the crystal structure by hand.
, in order to characterize the geometry. This correction factor, also often referred to as the geometric shape factor, is given by empirically determined series and accounts for the type and geometry of the crack or notch. We thus have:
Men have experienced difficulties in accepting and communicating about FM, as it was sometimes seen as a "woman's disease" and could thus impact their self-image. Well-known people who have had FM include Lady Gaga, Sinead O'Connor, Mary McDonough, Janeane Garofalo, Rosie Hamlin, Kirsty Young, Lena Dunham, and Morgan Freeman. Cricketer Don Bradman was diagnosed with fibrositis, an early term for fibromyalgia.
==== Blends of liquids ==== As for pure liquids, the viscosity of a blend of liquids is difficult to predict from molecular principles. One method is to extend the molecular "cage" theory presented above for a pure liquid. This can be done with varying levels of sophistication. One expression resulting from such an analysis is the Lederer–Roegiers equation for a binary mixture:
Sources: en.wikipedia.org
NMN is often measured by high-performance liquid chromatography with ultraviolet detection. Liquid chromatography-tandem mass spectrometry can provide greater sensitivity and specificity. The chosen method should be validated and compared against a certified reference standard when possible.
Cool temperatures slow chemical reactions that can degrade NMN over time. Moisture and light can also promote breakdown, so desiccated and light-protected containers are common. Storage recommendations may differ for dry powder and prepared solutions.
Related substances may include nicotinamide, nicotinamide riboside, and NAD+. Residual solvents or inorganic impurities can also be present depending on the manufacturing process. Purity testing aims to identify and limit these substances.
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ biosynthesis. It consists of nicotinamide, ribose, and phosphate groups.